MS Views and News Be empowered with MS views and news. To receive The MS BEACON e-Newsletter, CLICK HERE - -

Visit our MS learning channel on YouTube, which provides hundreds of MS educational videos presented by MS Experts from across the USA. Archived here: www.youtube.com/msviewsandnews -- Also please visit our Social media platforms: Facebook, Twitter, and Instagram . Each providing important information for the MS community. Furthermore, scroll down the left side of this blog to learn from the resources and links.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, for your personal knowledge and to keep you informed of current health-related issues. It is not a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~


Monday, June 6, 2011

Glycominds reports positive multiple sclerosis treatment results for relapse...

Results prove that the company's blood test can help identify which patients are likely to have a relapse within 24-60 months.

5 June 11 15:20, Yael Gruntman
Glycominds Ltd.  reported today that it had reached an important milestone in developing personalized therapy approaches for patients with multiple sclerosis. The company said that it has discovered a method for predicting clinical episodes in people who suffer from multiple sclerosis. These test results have proven with statistical significance that the gMS®Pro CDMS blood test has a good chance of identifying which patients are likely to have a relapse within 24-60 months.
The clinical test results were presented last weekend at the annual conference of the CMSC (Consortium of Multiple Sclerosis Centers) and confirm previous clinical results.
Results of the study, which took place in the Vall d’Hebron University Hospital in Barcelona, showed that patients who had already experienced an initial neural episode and tested positive in the Glycominds test, experienced a second episode within two years.


**************************************************************** 
Know somebody affected by Multiple Sclerosis?
Ask them to remain CURRENT with Multiple Sclerosis news & information 
 when registered at the  MS Views and News  website
.Weekly e-Newsletter now reaching (85) Countries. .
***************************************************************************************
Help STUART  to Educate:  Please donate   
- all contributions are tax deductible - 
We are a 501c3 - Not for Profit Charity
.
"Providing You with 'MS Views and News'is what we do"
***************************************************************************************
.
Disclaimer:  'MS Views and News' (MSVN), does not endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

No comments: